HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eugen Falk Selected Research

2- methyl- 6- (3- (2- phenyloxazol- 4- ylmethoxy)propoxymethyl)benzoic acid

1/2012AVE8134, a novel potent PPARĪ± agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats.
7/2009The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eugen Falk Research Topics

Disease

1Insulin Resistance
01/2012
1Body Weight (Weight, Body)
01/2012
1Hypertension (High Blood Pressure)
07/2009
1Hypertrophy
07/2009
1Fibrosis (Cirrhosis)
07/2009
1Cardiomegaly (Heart Hypertrophy)
07/2009
1Heart Failure
07/2009

Drug/Important Bio-Agent (IBA)

22- methyl- 6- (3- (2- phenyloxazol- 4- ylmethoxy)propoxymethyl)benzoic acidIBA
01/2012 - 07/2009
1Rosiglitazone (Avandia)FDA Link
01/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2009
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
07/2009
1SaltsIBA
07/2009
1PPAR alphaIBA
07/2009
1oxidized low density lipoproteinIBA
07/2009
1Desoxycorticosterone Acetate (DOCA)FDA Link
07/2009